Enhanced hypothalamic-pituitary-adrenocortical axis responses to physostigmine in normal aging

Area of Science:

• Neuroendocrinology
• Aging Research
• Pharmacology

Background:

• The hypothalamic-pituitary-adrenocortical (HPA) axis regulates stress response.
• Aging may alter HPA axis function.
• Physostigmine stimulates the HPA axis via central cholinergic pathways.

Purpose of the Study:

• To investigate the impact of normal human aging on the HPA axis response.
• To assess how aging affects the HPA axis's reaction to physostigmine.
• To understand the role of central cholinergic activity in age-related HPA axis changes.

Main Methods:

• Compared HPA axis hormonal responses (ACTH, beta-endorphin, cortisol) to physostigmine infusion in young and older adults.
• Administered a standardized dose of physostigmine (.0125 mg/kg) over 10 minutes.
• Measured plasma physostigmine levels to ensure comparable drug exposure between age groups.

Main Results:

• Older subjects exhibited significantly greater plasma ACTH, beta-endorphin, and cortisol levels post-physostigmine compared to younger subjects (p < .01 for all).
• No significant difference in plasma physostigmine concentrations was observed between the older and younger groups.
• This indicates that the enhanced hormonal response in older adults was not due to higher drug levels.

Conclusions:

• Normal human aging is associated with heightened HPA axis responsiveness to central cholinergic stimulation.
• The HPA axis in older individuals is more sensitive to drugs like physostigmine that increase CNS cholinergic activity.
• These findings highlight age-related changes in neuroendocrine regulation.